-
公开(公告)号:US20240360075A1
公开(公告)日:2024-10-31
申请号:US18640931
申请日:2024-04-19
Applicant: ALCON INC.
Inventor: Heeren M. Gordhan , Mitchell A. deLong , Jill M. Sturdivant , David Archer Ellis , Cynthia L. Lichorowic
IPC: C07C233/60 , A61K9/00 , A61K31/16 , A61K31/165 , A61K31/167 , A61K31/175 , A61K31/192 , A61K31/27 , A61K31/277 , A61K31/337 , A61K31/341 , A61K31/343 , A61K31/351 , A61K31/382 , A61K31/397 , A61K31/40 , A61K31/415 , A61K31/425 , A61K31/4465 , A61K31/495 , A61K31/5375 , A61K31/69 , A61K47/12 , A61K47/18 , A61K47/38 , C07C231/02 , C07C233/58 , C07C233/59 , C07C233/62 , C07C233/63 , C07C235/14 , C07C235/56 , C07C237/24 , C07C271/20 , C07C271/24 , C07C279/22 , C07C315/04 , C07C317/30 , C07D205/04 , C07D207/09 , C07D209/54 , C07D211/58 , C07D213/75 , C07D213/79 , C07D231/40 , C07D239/42 , C07D263/04 , C07D263/56 , C07D265/36 , C07D275/03 , C07D277/46 , C07D295/088 , C07D295/135 , C07D295/32 , C07D305/06 , C07D305/08 , C07D305/14 , C07D307/22 , C07D307/94 , C07D309/14 , C07D311/58 , C07D335/02 , C07F5/02
CPC classification number: C07C233/60 , A61K9/0048 , A61K31/16 , A61K31/165 , A61K31/167 , A61K31/175 , A61K31/192 , A61K31/27 , A61K31/277 , A61K31/337 , A61K31/341 , A61K31/343 , A61K31/351 , A61K31/382 , A61K31/397 , A61K31/40 , A61K31/415 , A61K31/425 , A61K31/4465 , A61K31/495 , A61K31/5375 , A61K31/69 , A61K47/12 , A61K47/183 , A61K47/186 , A61K47/38 , C07C231/02 , C07C233/58 , C07C233/59 , C07C233/62 , C07C233/63 , C07C235/14 , C07C235/56 , C07C237/24 , C07C271/20 , C07C271/24 , C07C279/22 , C07C315/04 , C07C317/30 , C07D205/04 , C07D207/09 , C07D209/54 , C07D211/58 , C07D213/75 , C07D213/79 , C07D231/40 , C07D239/42 , C07D263/04 , C07D263/56 , C07D265/36 , C07D275/03 , C07D277/46 , C07D295/088 , C07D295/135 , C07D295/32 , C07D305/06 , C07D305/08 , C07D305/14 , C07D307/22 , C07D307/94 , C07D309/14 , C07D311/58 , C07D335/02 , C07F5/025 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2602/18 , C07C2602/38 , C07C2602/42 , C07C2602/50
Abstract: Described herein are modified monoterpene TRPM8 activating compounds. In particular, provided herein are compounds that affect the function of ion channels in a cell, and are useful as therapeutic agents or with therapeutic agents. The compounds provided herein are useful in the treatment of a variety of diseases and conditions including inflammatory eye diseases such as uveitis, cardiovascular diseases, inflammatory diseases, and diseases characterized by abnormal growth, such as cancers.
-
公开(公告)号:US12043636B2
公开(公告)日:2024-07-23
申请号:US16950901
申请日:2020-11-17
Applicant: Covestro Deutschland AG
Inventor: Thomas Rölle , Horst Berneth , Dennis Hönel , Friedrich-Karl Bruder , Jürgen Kintrup
IPC: C07F5/02 , C07C211/63 , C07C211/64 , C07C217/08 , C07C219/10 , C07C219/28 , C07C219/30 , C07C271/12 , C07C271/16 , C07C271/20 , C07C271/24 , C07C271/28 , C07D213/20 , C07D233/02 , C07D233/58 , C07D247/00 , C07D295/037 , C07D309/34 , C07D335/02 , C07D347/00 , C07D413/06 , C07F5/04 , C07F9/54 , G03F7/00
CPC classification number: C07F5/027 , C07C211/63 , C07C211/64 , C07C217/08 , C07C219/10 , C07C219/28 , C07C219/30 , C07C271/12 , C07C271/16 , C07C271/20 , C07C271/24 , C07C271/28 , C07D213/20 , C07D233/02 , C07D233/58 , C07D247/00 , C07D295/037 , C07D309/34 , C07D335/02 , C07D347/00 , C07D413/06 , C07F5/04 , C07F9/54 , C07F9/5407 , C07F9/5442 , G03F7/001 , C07C2601/14
Abstract: The invention relates to a process for preparing triaryl organo borates proceeding from organoboronic esters in the presence of an n-valent cation 1/n Kn+, comprising the anhydrous workup of the reaction mixture and the use of the triaryl organoborates obtained as co-initiator in photopolymer formulations, holographic media and holograms.
-
公开(公告)号:US20230337677A1
公开(公告)日:2023-10-26
申请号:US17635631
申请日:2020-08-28
Inventor: Jeffrey R. Bloomquist , Quentin R. Coquerel , Gary M. Richoux , Maia Tsikolia , Liu Yang
IPC: A01N47/20 , C07C311/08 , A01N53/00 , A01N43/647 , A01N37/16 , A01N37/22 , C07C69/017 , C07D209/48 , C07C233/25 , A01P17/00 , A01N43/18 , C07D213/74 , C07C69/747 , A01N43/82 , C07D271/12 , C07D213/75 , A01N25/18 , C07C233/91 , A01N37/10 , C07D213/76 , C07D335/02 , A01N43/40 , C07C271/64 , C07D249/18 , A01N43/38 , A01N41/10 , C07C233/43 , C07C271/28 , C07C233/15 , C07C255/29 , C07C233/05 , A01N37/26 , C07C233/44 , C07C233/66
CPC classification number: A01N47/20 , C07C311/08 , A01N53/00 , A01N43/647 , A01N37/16 , A01N37/22 , C07C69/017 , C07D209/48 , C07C233/25 , A01P17/00 , A01N43/18 , C07D213/74 , C07C69/747 , A01N43/82 , C07D271/12 , C07D213/75 , A01N25/18 , C07C233/91 , A01N37/10 , C07D213/76 , C07D335/02 , A01N43/40 , C07C271/64 , C07D249/18 , A01N43/38 , A01N41/10 , C07C233/43 , C07C271/28 , C07C233/15 , C07C255/29 , C07C233/05 , A01N37/26 , C07C233/44 , C07C233/66 , C07C2601/10 , C07C2601/02
Abstract: The subject matter described herein is directed to compounds, synergistic compositions, and methods for repelling arthropods, such as insects. The compositions comprise aryl and pyridyl-type compounds. The compounds demonstrate strong vapor and topical repellency when applied alone and in synergistic compositions.
-
公开(公告)号:US20230075188A1
公开(公告)日:2023-03-09
申请号:US17948838
申请日:2022-09-20
Applicant: FUJIFILM Corporation
Inventor: Taro MIYOSHI , Eiji FUKUZAKI
IPC: G03F7/039 , G03F7/004 , G03F7/038 , C08F212/14 , C08F220/28 , C08F220/30 , C07C381/12 , C07C309/04 , C07D307/00 , C07D309/30 , C07D327/06 , C07D333/46 , C07D335/02 , C07D333/76 , C07C43/225 , C07C25/18
Abstract: The present invention provides an actinic ray-sensitive or radiation-sensitive resin composition containing (A) a resin having a polarity that increases by an action of an acid, and (B) a compound that generates an acid upon irradiation with actinic rays or radiation, represented by a specific general formula, is which the resin (A) includes a repeating unit represented by a specific general formula; and an actinic ray-sensitive or radiation-sensitive film formed of the actinic ray-sensitive or radiation-sensitive resin composition, a pattern forming method, and a method for manufacturing an electronic device.
-
公开(公告)号:US11487203B2
公开(公告)日:2022-11-01
申请号:US15858129
申请日:2017-12-29
Inventor: Eui Hyun Ryu , Myung-Yeol Kim , Woo-Hyung Lee , Haemi Jeong , Kwang-Hwyi Im
IPC: G03F7/039 , G03F7/38 , C08F220/28 , C08F220/38 , C08F220/68 , G03F7/038 , C07C323/13 , C07C69/54 , C08L33/10 , C07D327/06 , C07D331/00 , C07D327/00 , C07D335/02 , C09D133/06 , C07D307/20 , C07C323/17 , C07D309/10
Abstract: Monomers and polymers are provided that comprise a carbon alicyclic group or heteroalicyclic group that comprises 1) one or more acid-labile ring substituents and 2) one or more ether or thioether ring substituents. Photoresists that comprise such polymers also are provided.
-
公开(公告)号:US20220055985A1
公开(公告)日:2022-02-24
申请号:US17463011
申请日:2021-08-31
Applicant: The Liver Company Inc.
Inventor: Julie FARAND , Joshua A. KAPLAN , Gregory NOTTE , Casey Lockwood OLEN , Michael SANGI , David SPERANDIO
IPC: C07C323/25 , C07C323/30 , C07C323/31 , C07D205/04 , C07D207/48 , C07D213/89 , C07D231/18 , C07D235/00 , C07D239/26 , C07D257/04 , C07D275/02 , C07D277/36 , C07D295/116 , C07D305/08 , C07D309/08 , C07D335/02 , C07D451/02 , C07D493/08 , C07F9/50 , C07C313/06 , A61K31/18 , C07C311/08 , C07C311/21 , C07C311/39 , C07C311/29 , C07C311/46 , C07C311/14 , C07C311/13
Abstract: Provided is a compound of Formula (I): wherein the variable groups are defined herein.
-
公开(公告)号:US20220054486A1
公开(公告)日:2022-02-24
申请号:US17185278
申请日:2021-02-25
Applicant: InventisBio LLC
Inventor: Xing DAI , Yaolin Wang
IPC: A61K31/505 , A61K31/196 , A61K31/351 , A61K31/382 , A61K31/41 , A61K31/415 , A61K31/4155 , A61K31/4184 , C07C275/42 , C07D233/88 , C07D239/42 , C07D257/04 , C07D261/14 , C07D309/08 , C07D309/14 , C07D335/02 , C07D413/12
Abstract: The present disclosure provides compounds of Formula (I). The compounds described herein may be useful in treating a disease associated with IDO, for example, cancer or an infectious disease (e.g., viral or bacterial infectious diseases). Also, provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
-
公开(公告)号:US10899754B2
公开(公告)日:2021-01-26
申请号:US16464858
申请日:2017-12-15
IPC: C07D417/12 , C07D417/14 , C07D405/12 , C07D285/08 , C07D241/06 , C07D233/88 , C07D233/90 , C07D213/04 , C07D249/14 , C07D237/20 , C07C229/42 , C07D207/50 , C07D213/74 , C07D235/00 , C07D235/30 , C07D241/20 , C07D257/06 , C07D263/48 , C07D271/113 , C07D277/42 , C07D277/82 , C07D305/08 , C07D333/36 , C07D335/02 , C07D413/12 , C07D417/04 , C07D471/04
Abstract: Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases such as chronic viral infection, chronic bacterial infections, cancer, sepsis or a neurological disorder.
-
公开(公告)号:US10881656B2
公开(公告)日:2021-01-05
申请号:US15431967
申请日:2017-02-14
Applicant: The General Hospital Corporation
Inventor: Othon Iliopoulos , Michael Albert Zimmer
IPC: A61K31/381 , A61K31/38 , A61K31/473 , A61K31/138 , A61K31/166 , A61K31/167 , A61K31/366 , A61K31/382 , A61K31/5575 , A61K45/06 , C07C225/16 , C07C235/38 , C07C237/46 , C07D219/14 , C07D309/38 , C07D333/22 , C07D333/38 , C07D335/02 , A61K31/137
Abstract: The present invention is directed to HIF inhibitors and methods of preventing cell proliferation, reducing inflammation, and treating an angiogenic disease or disorders.
-
公开(公告)号:US10858317B2
公开(公告)日:2020-12-08
申请号:US16383049
申请日:2019-04-12
Applicant: Global Blood Therapeutics, Inc.
IPC: C07D207/08 , C07C271/16 , C07D207/34 , C07D211/22 , C07D211/60 , C07D211/78 , C07D213/81 , C07D241/04 , C07D265/30 , C07D279/12 , C07D309/08 , C07D309/28 , C07D333/38 , C07D335/02 , C07D401/06 , C07D211/16 , C07D401/12 , C07D207/48 , C07D403/06
Abstract: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
-
-
-
-
-
-
-
-